Records containing: Opioid-use Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-02-25Testing the Effects of Contingency Management and Behavioral Economics on Buprenorphine-Naloxone Treatment Adherence Using a Sequential Multiple Assignment Randomized Trial (SMART) Design
-
CLINICAL_TRIALS study record update · 2025-02-21Subthreshold Opioid Use Disorder Prevention (STOP) Trial
-
CLINICAL_TRIALS study record update · 2025-02-14Randomized Controlled Trial of Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder Patients Using Fentanyl
-
CLINICAL_TRIALS study record update · 2025-02-07Impact of Lofexidine on Stress, Craving and Opioid Use
-
CLINICAL_TRIALS study record update · 2025-01-30PRescribing INterventions for Chronic Pain Via the Electronic Health Record Study - Current Opioid-User Population
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-01-24Mindful Body Awareness Training as an Adjunct to Medication Treatment for Opioid Use Disorder
-
CLINICAL_TRIALS study record update · 2025-01-14Substance Use Treatment and Recovery Team
-
CLINICAL_TRIALS study record update · 2025-01-10Emergency Department-Initiated Buprenorphine Validation Network Trial
-
CLINICAL_TRIALS study record update · 2025-01-09Treating Posttraumatic Stress Disorder in Patients With Opioid Use Disorder
-
CLINICAL_TRIALS study record update · 2025-01-06A Phase 1 Study Investigating the Safety, Tolerability and Pharmacokinetics of KNX100 in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2024-12-20Functional Near Infrared Spectroscopy-based Neurofeedback to Reduce Relapse in Prescription Opioid/Alcohol Use Disorders
-
CLINICAL_TRIALS study record update · 2024-12-13A Prospective, Randomized Trial of the Effect of Buprenorphine Continuation Versus Dose Reduction on Pain Control and Post-Operative Opioid Use
-
CLINICAL_TRIALS study record update · 2024-12-12Ending Transmission of HIV, HCV, and STDs and Overdose in Rural Communities of People Who Inject Drugs (ETHIC)
-
CLINICAL_TRIALS study record update · 2024-11-27Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure
-
CLINICAL_TRIALS study record update · 2024-11-12Feasibility of Pediatric Emergency Department-Initiated Treatment for Adolescents With Opioid Use Disorder
-
CLINICAL_TRIALS study record update · 2024-11-06Enhancing Office-based Buprenorphine Treatment: An Adaptive Psychosocial Approach
-
CLINICAL_TRIALS study record update · 2024-11-04Safety, Efficacy, Pharmacokinetics, and Pharmacogenomics of Extended-Release Naltrexone in Pregnant Women
-
CLINICAL_TRIALS study record update · 2024-11-01Integrated Intervention Combining CBT4CBT-Buprenorphine + Recovery Coach for Office-based Buprenorphine
-
CLINICAL_TRIALS study record update · 2024-10-31FAVOR Opioid Recovery Coaching Evaluation
-
CLINICAL_TRIALS study record update · 2024-09-25Dual-Orexin Antagonism As a Mechanism for Improving Sleep and Drug Abstinence in Opioid Use Disorder
-
CLINICAL_TRIALS study record update · 2024-08-30The Heroes Circle Opioid Project
-
CLINICAL_TRIALS study record update · 2024-08-30Achieving Smoking Cessation Milestones in Opioid Treatment Patients: a Randomized 2 x 2 Factorial Trial of Directly Observed and Long-term Varenicline
-
CLINICAL_TRIALS study record update · 2024-08-26PRescribing INterventions for Chronic Pain Via the Electronic Health Record Study - Opioid-Naive Population
-
CLINICAL_TRIALS study record update · 2024-08-21A Phase I Double-Blind, Placebo-Controlled Randomized Study to Assess Repeated Doses of INDV-2000 (C4X_3256) up to 28 Days in Healthy Volunteers, and an Open-Label Study of INDV-2000 up to 11 Days in Treatment Seeking Individuals With Opioid Use Disorder
-
CLINICAL_TRIALS study record update · 2024-08-13Test of a Workforce Development Intervention to Expand Buprenorphine Prescribers